Tags

Type your tag names separated by a space and hit enter

Communication between gastrointestinal bacteria and the nervous system.
Curr Opin Pharmacol. 2012 Dec; 12(6):667-72.CO

Abstract

In the past few years, intestinal microbiota has emerged as a novel target for the treatment of gut-brain axis alterations. These include functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric conditions. Thus, modulation of the microbiota (e.g. with the use of probiotics) could be proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for psychiatric treatment of anxiety and depression.

Authors+Show Affiliations

Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile. javier.bravo@ucv.clNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

23041079

Citation

Bravo, Javier A., et al. "Communication Between Gastrointestinal Bacteria and the Nervous System." Current Opinion in Pharmacology, vol. 12, no. 6, 2012, pp. 667-72.
Bravo JA, Julio-Pieper M, Forsythe P, et al. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol. 2012;12(6):667-72.
Bravo, J. A., Julio-Pieper, M., Forsythe, P., Kunze, W., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2012). Communication between gastrointestinal bacteria and the nervous system. Current Opinion in Pharmacology, 12(6), 667-72. https://doi.org/10.1016/j.coph.2012.09.010
Bravo JA, et al. Communication Between Gastrointestinal Bacteria and the Nervous System. Curr Opin Pharmacol. 2012;12(6):667-72. PubMed PMID: 23041079.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Communication between gastrointestinal bacteria and the nervous system. AU - Bravo,Javier A, AU - Julio-Pieper,Marcela, AU - Forsythe,Paul, AU - Kunze,Wolfgang, AU - Dinan,Timothy G, AU - Bienenstock,John, AU - Cryan,John F, Y1 - 2012/10/04/ PY - 2012/06/01/received PY - 2012/07/20/revised PY - 2012/09/19/accepted PY - 2012/10/9/entrez PY - 2012/10/9/pubmed PY - 2013/5/11/medline SP - 667 EP - 72 JF - Current opinion in pharmacology JO - Curr Opin Pharmacol VL - 12 IS - 6 N2 - In the past few years, intestinal microbiota has emerged as a novel target for the treatment of gut-brain axis alterations. These include functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), which can be comorbid with stress-related psychiatric conditions. Thus, modulation of the microbiota (e.g. with the use of probiotics) could be proposed as a novel strategy not only for the treatment of IBS but also as an adjuvant for psychiatric treatment of anxiety and depression. SN - 1471-4973 UR - https://www.unboundmedicine.com/medline/citation/23041079/Communication_between_gastrointestinal_bacteria_and_the_nervous_system_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1471-4892(12)00179-8 DB - PRIME DP - Unbound Medicine ER -